跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Prestan Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Prestan Plus
Approved
STANDARD
Prestan Plus
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6b78f1846e0685de
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
6b78f1846e0685de
Drug Approval Philippines Name
Prestan Plus
Product Name
Prestan Plus
Registration Number
DRP-2669
Brand Name
Prestan Plus
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg /12.5 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
Actimed, Inc.
Issuance Date
24 November 2020
Expiry Date
03 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6b78f1846e0685de
Type
Standard
Back to Philippines FDA Approvals